KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Change in Inventory (2016 - 2026)

Medtronic (MDT) has disclosed Change in Inventory for 13 consecutive years, with $131.0 million as the latest value for Q1 2026.

  • Quarterly Change in Inventory fell 34.5% to $131.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $617.0 million through Jan 2026, up 609.2% year-over-year, with the annual reading at $292.0 million for FY2025, 110.07% up from the prior year.
  • Change in Inventory hit $131.0 million in Q1 2026 for Medtronic, down from $299.0 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $410.0 million in Q3 2023 to a low of -$391.0 million in Q2 2024.
  • Historically, Change in Inventory has averaged $151.6 million across 5 years, with a median of $201.0 million in 2022.
  • Biggest five-year swings in Change in Inventory: soared 406.67% in 2022 and later plummeted 13133.33% in 2024.
  • Year by year, Change in Inventory stood at $404.0 million in 2022, then tumbled by 49.01% to $206.0 million in 2023, then crashed by 70.39% to $61.0 million in 2024, then soared by 390.16% to $299.0 million in 2025, then tumbled by 56.19% to $131.0 million in 2026.
  • Business Quant data shows Change in Inventory for MDT at $131.0 million in Q1 2026, $299.0 million in Q4 2025, and $373.0 million in Q3 2025.